378 related articles for article (PubMed ID: 8174495)
41. Carbapenems: monotherapy in intra-abdominal sepsis.
Wilson SE
Scand J Infect Dis Suppl; 1995; 96():28-33. PubMed ID: 7652500
[TBL] [Abstract][Full Text] [Related]
42. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
Caldwell JW; Singh S; Johnson RH
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():129-34. PubMed ID: 10225583
[TBL] [Abstract][Full Text] [Related]
43. Clinical evaluation of imipenem/cilastatin in the therapy of severe infections in high-risk patients.
Cristiano P
Drugs Exp Clin Res; 1989; 15(1):17-20. PubMed ID: 2743870
[TBL] [Abstract][Full Text] [Related]
44. Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.
Colardyn F; Faulkner KL
J Antimicrob Chemother; 1996 Sep; 38(3):523-37. PubMed ID: 8889726
[TBL] [Abstract][Full Text] [Related]
45. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
[TBL] [Abstract][Full Text] [Related]
46. A randomized controlled trial of ampicillin plus sulbactam vs. gentamicin plus clindamycin in the treatment of intraabdominal infections: a preliminary report. Study Group of Intraabdominal Infections.
Rev Infect Dis; 1986; 8 Suppl 5():S583-8. PubMed ID: 2879345
[TBL] [Abstract][Full Text] [Related]
47. Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection.
Lucasti C; Vasile L; Sandesc D; Venskutonis D; McLeroth P; Lala M; Rizk ML; Brown ML; Losada MC; Pedley A; Kartsonis NA; Paschke A
Antimicrob Agents Chemother; 2016 Oct; 60(10):6234-43. PubMed ID: 27503659
[TBL] [Abstract][Full Text] [Related]
48. A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group.
Barie PS; Vogel SB; Dellinger EP; Rotstein OD; Solomkin JS; Yang JY; Baumgartner TF
Arch Surg; 1997 Dec; 132(12):1294-302. PubMed ID: 9403533
[TBL] [Abstract][Full Text] [Related]
49. [Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
Pérez C; Sirham M; Labarca J; Grebe G; Lira P; Oliva J; Duhalde M; Ocqueteau M; Acuña G
Rev Med Chil; 1995 Mar; 123(3):312-20. PubMed ID: 8525170
[TBL] [Abstract][Full Text] [Related]
50. Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections.
Solomkin JS; Dellinger EP; Christou NV; Busuttil RW
Ann Surg; 1990 Nov; 212(5):581-91. PubMed ID: 2241313
[TBL] [Abstract][Full Text] [Related]
51. Comparison of piperacillin/tazobactam and imipenem/cilastatin, both in combination with tobramycin, administered every 6 h for treatment of nosocomial pneumonia.
Joshi M; Metzler M; McCarthy M; Olvey S; Kassira W; Cooper A
Respir Med; 2006 Sep; 100(9):1554-65. PubMed ID: 16487695
[TBL] [Abstract][Full Text] [Related]
52. [Contribution of imipenem/cilastatin in the treatment of peritonitis: a comparative economic analysis in the case of France].
Levy E; Levy P
J Chir (Paris); 1993 Apr; 130(4):200-9. PubMed ID: 8345014
[TBL] [Abstract][Full Text] [Related]
53. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.
Fink MP; Snydman DR; Niederman MS; Leeper KV; Johnson RH; Heard SO; Wunderink RG; Caldwell JW; Schentag JJ; Siami GA
Antimicrob Agents Chemother; 1994 Mar; 38(3):547-57. PubMed ID: 8203853
[TBL] [Abstract][Full Text] [Related]
54. A multicenter, randomized controlled clinical study on biapenem and imipenem/cilastatin injection in the treatment of respiratory and urinary tract infections.
Jia B; Lu P; Huang W; Li C; Huang A; Zhou X; Zhang W; Wu G; Zhang G
Chemotherapy; 2010; 56(4):285-90. PubMed ID: 20714145
[TBL] [Abstract][Full Text] [Related]
55. Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis.
Jaccard C; Troillet N; Harbarth S; Zanetti G; Aymon D; Schneider R; Chiolero R; Ricou B; Romand J; Huber O; Ambrosetti P; Praz G; Lew D; Bille J; Glauser MP; Cometta A
Antimicrob Agents Chemother; 1998 Nov; 42(11):2966-72. PubMed ID: 9797234
[TBL] [Abstract][Full Text] [Related]
56. Ceftazidime/clindamycin versus tobramycin/clindamycin in the treatment of intra-abdominal infections.
Bubrick MP; Heim-Duthoy KL; Yellin AE; Berne TV; Heseltine PN; Appleman MD; Cocchetto DM; Matzke GR
Am Surg; 1990 Oct; 56(10):613-7. PubMed ID: 2221611
[TBL] [Abstract][Full Text] [Related]
57. Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial.
Chen Z; Wu J; Zhang Y; Wei J; Leng X; Bi J; Li R; Yan L; Quan Z; Chen X; Yu Y; Wu Z; Liu D; Ma X; Maroko R; Cooper A
BMC Infect Dis; 2010 Jul; 10():217. PubMed ID: 20663130
[TBL] [Abstract][Full Text] [Related]
58. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
[TBL] [Abstract][Full Text] [Related]
59. The efficacy and safety of imipenem/cilastatin in the treatment of severe bacterial infections.
D'Amato C; Armignacco O; Antonucci G; Bordi E; Bove G; De Carli G; De Mori P; Rosci MA; Visco G
J Chemother; 1990 Apr; 2(2):100-7. PubMed ID: 2193998
[TBL] [Abstract][Full Text] [Related]
60. Management of surgical infections.
Kosmidis J
Scand J Gastroenterol Suppl; 1984; 90():71-5. PubMed ID: 6588483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]